Nanomedicine for combination of chemodynamic therapy and immunotherapy of cancers
Biomaterials Science · 2024 · 12 (18) · 4607-4629
DOI: 10.1039/d3bm02133e ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2024. Verfasst von Waqas Ahmad und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Xi'an Jiaotong University, Xi'an 710049, Shaanxi, China. gezs@ustc.edu.cn. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Nanomedicine. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The combination of chemodynamic therapy (CDT) with immunotherapy can result in enhanced therapeutic effects of cancers. The recent progresses and challenges concerning nanomedicine for combination of CDT and immunotherapy are summarized and discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Xi'an Jiaotong University, Xi'an 710049, Shaanxi, China. gezs@ustc.edu.cn.
- CAS Key Laboratory of Soft Matter Chemistry, Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei 230026, Anhui, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ahmad, W., Sajjad, W., Zhou, Q., & Ge, Z. (2024). Nanomedicine for combination of chemodynamic therapy and immunotherapy of cancers. Biomaterials Science, 12(18), 4607-4629. https://doi.org/10.1039/d3bm02133e
Vancouver
Ahmad W, Sajjad W, Zhou Q, Ge Z. Nanomedicine for combination of chemodynamic therapy and immunotherapy of cancers. Biomaterials Science. 2024;12(18):4607-4629. doi:10.1039/d3bm02133e
BibTeX
@article{Ahmad2024,
author = {Ahmad, Waqas and Sajjad, Wasim and Zhou, Qinghao and Ge, Zhishen},
title = {Nanomedicine for combination of chemodynamic therapy and immunotherapy of cancers},
journal = {Biomaterials Science},
year = {2024},
volume = {12},
number = {18},
pages = {4607--4629},
doi = {10.1039/d3bm02133e}
}
EUVIMED